These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11325856)

  • 1. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.
    Guan XY; Sham JS; Tang TC; Fang Y; Huo KK; Yang JM
    Cancer Res; 2001 May; 61(9):3806-9. PubMed ID: 11325856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic role of eIF-5A2 in the development of ovarian cancer.
    Guan XY; Fung JM; Ma NF; Lau SH; Tai LS; Xie D; Zhang Y; Hu L; Wu QL; Fang Y; Sham JS
    Cancer Res; 2004 Jun; 64(12):4197-200. PubMed ID: 15205331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
    Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.
    Xie D; Ma NF; Pan ZZ; Wu HX; Liu YD; Wu GQ; Kung HF; Guan XY
    Hum Pathol; 2008 Jan; 39(1):80-6. PubMed ID: 17949776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation initiation factor eIF-5A from Plasmodium falciparum.
    Molitor IM; Knöbel S; Dang C; Spielmann T; Alléra A; König GM
    Mol Biochem Parasitol; 2004 Sep; 137(1):65-74. PubMed ID: 15279952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two novel Trichomonas vaginalis eif-5a genes.
    Carvajal-Gamez B; Arroyo R; Lira R; López-Camarillo C; Alvarez-Sánchez ME
    Infect Genet Evol; 2010 Mar; 10(2):284-91. PubMed ID: 20060503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
    Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
    Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using region-specific multiplex fluorescence in situ hybridization probes.
    Tjia WM; Sham JS; Hu L; Tai AL; Guan XY
    Cancer Genet Cytogenet; 2005 Apr; 158(1):61-6. PubMed ID: 15771906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.
    Guan XY; Xu J; Anzick SL; Zhang H; Trent JM; Meltzer PS
    Cancer Res; 1996 Aug; 56(15):3446-50. PubMed ID: 8758910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma.
    Guan XY; Cargile CB; Anzick SL; Thompson FH; Meltzer PS; Bittner ML; Taetle R; McGill JR; Trent JM
    Cancer Res; 1995 Aug; 55(15):3380-5. PubMed ID: 7614475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
    Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
    Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
    Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
    Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.
    Chen W; Luo JH; Hua WF; Zhou FJ; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):400-8. PubMed ID: 19155439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.
    Lambros MB; Fiegler H; Jones A; Gorman P; Roylance RR; Carter NP; Tomlinson IP
    J Pathol; 2005 Jan; 205(1):29-40. PubMed ID: 15586366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines.
    Imoto I; Pimkhaokham A; Watanabe T; Saito-Ohara F; Soeda E; Inazawa J
    Biochem Biophys Res Commun; 2000 Sep; 276(1):264-70. PubMed ID: 11006116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability.
    Chen M; Huang JD; Deng HK; Dong S; Deng W; Tsang SL; Huen MS; Chen L; Zan T; Zhu GX; Guan XY
    BMC Cancer; 2011 May; 11():199. PubMed ID: 21612665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
    Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
    Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
    Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
    Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIF5A2 is a novel chemoresistance gene in breast cancer.
    Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
    Breast Cancer; 2015 Nov; 22(6):602-7. PubMed ID: 24638963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.